High Blood Pressure and Heart Disease

A study to evaluate whether the new medication can help prevent heart attacks, strokes, heart failure and cardiac death.

Enquire Now

Sex
I consent to be contacted via text, email or phone(Required)
How would you like to be contacted?
Where did you hear about us?

We use this to understand which recruitment methods are working.
Privacy Notice we will only use your personal information for administration purposes and to provide information on upcoming medical trials relevant to you. Please read our full Privacy Notice and accept - Click Here
I have read Ormeau Clinical Trials Privacy Notice and agree(Required)

Trial Overview

This study is to evaluate whether the study medication can help prevent heart attacks, strokes, heart failure and/or cardiac death, and to find out what effects the new medication has on people, as an add-on to current medications.

Participation in this study is expected to last for 2 – 5 years depending upon when the study is joined. There will be 10 – 14 visits to the study clinic during this period.

Participation Criteria

  • Have or are at high risk of cardiovascular diseases (heart attack, stroke, vascular disease)
  • Have high blood pressure in spite of taking at least 2 medications for high blood pressure

What is High Blood Pressure and Heart Disease?

High Blood Pressure (Hypertension) is persistently high blood pressure that often has no symptoms but gradually damages blood vessels and organs over time. Cardiovascular disease (CVD), commonly referred to as Heart Disease, covers conditions affecting the heart and blood vessels, including coronary artery disease, heart attack, and stroke. High Blood Pressure is one of the biggest risk factors for CVD, as sustained high pressure accelerates artery damage and narrowing (atherosclerosis), increasing the risk of clots, heart attack, and stroke. Managing blood pressure through lifestyle changes and medication is a key way to reduce CVD risk.

Find out more: 

Complete the enquiry form and a member of staff will be in contact to discuss further.

Call us on 028 9027 8380 to discuss with the team.